Citation Impact
Citing Papers
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
2003
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Molecular Markers for Predicting Response to Tamoxifen in Breast Cancer Patients
2000
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
2019 Standout
Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote Metastasis
2017 StandoutNobel
Cost‐effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2‐positive breast cancer
2007
Head and neck squamous cell carcinoma
2020 Standout
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis
2001
Hepatocellular carcinoma
2003 Standout
The toxicology of aflatoxins as a basis for public health decisions
2002
Cytochrome P450 epoxygenases as EDHF synthase(s)
2004
Molecular pathogenesis of human hepatocellular carcinoma
2002
Ovarian cancer: strategies for overcoming resistance to chemotherapy
2003
Molecular mechanism of emodin action: Transition from laxative ingredient to an antitumor agent
2006
ROS production and protein oxidation as a novel mechanism for seed dormancy alleviation
2007 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Assembly of the Warfarin-sensitive Vitamin K 2,3-Epoxide Reductase Enzyme Complex in the Endoplasmic Reticulum Membrane
1997
High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance
2001
Hepatocellular carcinoma
2000
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study
2012 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
The biochemistry and medical significance of the flavonoids
2002 Standout
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer
2003
Glial and neuronal control of brain blood flow
2010 StandoutNature
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
2007 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Organocatalytic Asymmetric Hydrolysis of Epoxides
2014 StandoutNobel
Systems biology of cisplatin resistance: past, present and future
2014
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Epoxide hydrolases: their roles and interactions with lipid metabolism
2005
A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects
2013 Standout
Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver
2007
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Mycotoxins and human disease: a largely ignored global health issue
2009 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Anti‐cancer properties of anthraquinones from rhubarb
2006 Standout
The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy
2009
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression
2008 StandoutNobel
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Biological effects of essential oils – A review
2007 Standout
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols
2005
ERBB2-Mediated Transcriptional Up-regulation of the α5β1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions
2006
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
2019 Standout
Organokatalytische asymmetrische Hydrolyse von Epoxiden
2014 StandoutNobel
Relationship between the microsomal epoxide hydrolase and the hepatocellular transport of bile acids and xenobiotics
1995
Evaluation of mutagenic and antimutagenic activities of α-bisabolol in the Salmonella/microsome assay
2005
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
EPOXIDE HYDROLASES: Mechanisms, Inhibitor Designs, and Biological Roles
2004
Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology
2005 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.
2012
The Influence of Repair Pathways on the Cytotoxicity and Mutagenicity Induced by the Pyridyloxobutylation Pathway of Tobacco-Specific Nitrosamines
2009 StandoutNobel
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Targeted Disruption of the Microsomal Epoxide Hydrolase Gene
1999
Works of Roger Becker being referenced
Prognostic Significance of c-erbB-2 mRNA in Ovarian Carcinoma
1996
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer
1999
The Human P53 Gene Mutated At Position 249 Per Se Is Not Sufficient to Immortalize Human Liver Cells
1999
cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal controlin vitro andin vivo
2001
mdm2 mRNA expression is associated with survival in ovarian cancer
1997
The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells
1997
C-myc mRNA Expression in Epithelial Ovarian Carcinomas in Relation to Estrogen Receptor Status, Metastatic Spread, Survival Time, FIGO Stage, and Histologie Grade and Type
1998
Studies on the importance of microsomal epoxide hydrolase in the detoxification of arene oxides using the heterologous expression of the enzyme in mammalian cells
1994
The microsomal epoxide hydrolase has a single membrane signal anchor sequence which is dispensable for the catalytic activity of this protein
1994
The cost effectiveness of tamoxifen in the prevention of breast cancer.
1999